Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Jamieson Wellness Inc ( (TSE:JWEL) ) has shared an update.
Jamieson Wellness Inc. reported strong second quarter results for 2025, with a 13.8% increase in branded revenue, driven by successful marketing and promotional strategies across key markets. The company’s growth was highlighted by a 73% increase in its Chinese market due to the effective 6/18 program, alongside notable gains in Canada and the U.S. The results reflect Jamieson’s strategic execution and innovation in product offerings, which have bolstered its market position and operational performance, leading to increased dividends and a focus on global expansion.
The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.
Spark’s Take on TSE:JWEL Stock
According to Spark, TipRanks’ AI Analyst, TSE:JWEL is a Outperform.
Jamieson Wellness Inc. has a strong financial foundation and positive corporate developments, particularly in expanding its market presence in China. However, technical indicators suggest caution in the short term, and the valuation appears high, which may limit upside potential.
To see Spark’s full report on TSE:JWEL stock, click here.
More about Jamieson Wellness Inc
Jamieson Wellness Inc. operates in the health and wellness industry, focusing on providing trusted brands and products that promote better living. The company is known for its branded health products, including vitamins and supplements, with a market focus that spans Canada, the United States, China, and international markets in the Middle East and Southeast Asia.
Average Trading Volume: 55,612
Technical Sentiment Signal: Strong Buy
Current Market Cap: C$1.43B
See more data about JWEL stock on TipRanks’ Stock Analysis page.